AMBER ABELN: Open Payments
NPI 1720275027 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 91 payments from 17 companies in 2025. Trend: 2023 $998 · 2024 $1,330 · 2025 $1,750
Food & beverage: $1,650Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $483 |
| ABBVIE INC. | 23 | $277 |
| Galderma Laboratories, L.P. | 9 | $161 |
| UCB, Inc. | 8 | $137 |
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Lilly USA, LLC | 8 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| Amgen Inc. | 4 | $82 |
| Incyte Corporation | 2 | $48 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $43 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, Bimzelx, DUPIXENT, TALTZ, RINVOQ, Otezla.
Industry payments across MO — which companies pay providers there.
